Joseph Kaplinsky

Joseph Kaplinsky

Auto-generated profile, based on publicly available information

Joseph Kaplinsky

Department of Pathology Beth Israel Deaconess Medical Center 02215 Boston MA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2016 in Nature Communications
Verified
Journal Article
Open access
JKJoseph Kaplinsky
Joseph Kaplinsky
RARamy Arnaout
Ramy Arnaout
The diversity of an organism’s B- and T-cell repertoires is both clinically important and a key measure of immunological complexity. However, diversity is hard to estimate by current methods, because of inherent uncertainty in the number of B- and T-cell clones that will be missing from a blood or tissue sample by chance (the missing-species problem), inevitable sampling bias, and experimental noise. To solve this problem, we developed Recon, a modified maximum-likelihood method that outputs the overall diversity of a repertoire from measurements on a sample. Recon outputs accurate, robust estimates by any of a vast set of complementary diversity measures, including species richness and entropy, at fractional repertoire coverage. It also outputs error bars and power tables, allowing robust comparisons of diversity between individuals and over time. We apply Recon toin silicoand experimental immune-repertoire sequencing data sets as proof of principle for measuring diversity in large, complex systems.

23 February 2011 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
ASAli Salehi-Reyhani
Ali Salehi-Reyhani
JKJoseph Kaplinsky
Joseph Kaplinsky
EBEdward Burgin
Edward Burgin
MNMiroslava Novakova
Miroslava Novakova
ADAndrew J. Demello
Andrew J. Demello
DKDavid Klug
David Klug
We have developed a generic platform to undertake the analysis of protein copy number from single cells. The approach described here is ‘all-optical’ whereby single cells are manipulated into separate analysis chambers using an optical trap; single cells are lysed by a shock wave caused by laser-induced microcavitation, and the protein released from a single cell is measured by total internal reflection microscopy as it is bound to micro-printed antibody spots within the device. The platform was tested using GFP transfected cells and the relative precision of the measurement method was determined to be 88%. Single cell measurements were also made on a breast cancer cell line to measure the relative levels of unlabelled human tumour suppressor protein p53 using a chip incorporating an antibody sandwich assay format. These results suggest that this is a viable method for measuring relative protein levels in single cells.

9 June 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JKJoseph Kaplinsky
Joseph Kaplinsky
ALAnthony Li
Anthony Li
ASAmy Sun
Amy Sun
MCMaryaline Coffre
Maryaline Coffre
SKSergei Koralov
Sergei Koralov
RARamy Arnaout
Ramy Arnaout
Antibody repertoires are known to be shaped by selection for antigen binding. Unexpectedly, we now show that selection also acts on a non–antigen-binding antibody region: the heavy-chain variable (VH)–encoded “elbow” between variable and constant domains. By sequencing 2.8 million recombined heavy-chain genes from immature and mature B-cell subsets in mice, we demonstrate a striking gradient in VH gene use as pre-B cells mature into follicular and then into marginal zone B cells. Cells whose antibodies use VH genes that encode a more flexible elbow are more likely to mature. This effect is distinct from, and exceeds in magnitude, previously described maturation-associated changes in heavy-chain complementarity determining region 3, a key antigen-binding region, which arise from junctional diversity rather than differential VH gene use. Thus, deep sequencing reveals a previously unidentified mode of B-cell selection.

1 January 2020 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
MVMilena Vujovic
Milena Vujovic
KDKristine Fredlund Degn
Kristine Fredlund Degn
FMFrederikke Isa Marin
Frederikke Isa Marin
ASAnna-Lisa Schaap-Johansen
Anna-Lisa Schaap-Johansen
BCBenny Chain
Benny Chain
PMPaolo Marcatili
Paolo Marcatili
There has been increasing interest in the role of T cells and their involvement in cancer, autoimmune and infectious diseases. However, the nature of T cell receptor (TCR) epitope recognition at a repertoire level is not yet fully understood. Due to technological advances a plethora of TCR sequences from a variety of disease and treatment settings has become readily available. Current efforts in TCR specificity analysis focus on identifying characteristics in immune repertoires which can explain or predict disease outcome or progression, or can be used to monitor the efficacy of disease therapy. In this context, clustering of TCRs by sequence to reflect biological similarity, and especially to reflect antigen specificity have become of paramount importance. We review the main TCR sequence clustering methods and the different similarity measures they use, and discuss their performance and possible improvement. We aim to provide guidance for non-specialists who wish to use TCR repertoire sequencing for disease tracking, patient stratification or therapy prediction, and to provide a starting point for those aiming to develop novel techniques for TCR annotation through clustering.

11 March 2014 in The Analyst
Verified
Journal Article
Closed access
PDF file
EBEdward Burgin
Edward Burgin
ASAli Salehi-Reyhani
Ali Salehi-Reyhani
MBMichael Barclay
Michael Barclay
ABAidan Brown
Aidan Brown
JKJoseph Kaplinsky
Joseph Kaplinsky
DKDavid R. Klug
David R. Klug
We report the use of a microfluidic microarray incorporating single molecule detection for the absolute quantification of protein copy number in solution. In this paper we demonstrate protocols which enable calibration free detection for two protein detection assays. An EGFP protein assay has a limit of detection of <30 EGFP proteins in a microfluidic analysis chamber (limited by non-specific background binding), with a measured limit of linearity of approximately 6 × 106 molecules of analyte in the analysis chamber and a dynamic range of >5 orders of magnitude in protein concentration. An antibody sandwich assay was used to detect unlabelled human tumour suppressor protein p53 with a limit of detection of approximately 21 p53 proteins and a dynamic range of >3 orders of magnitude. We show that these protocols can be used to calibrate data retrospectively to determine the absolute protein copy number at the single cell level in two human cancer cell lines.

27 August 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
JRJohn Rizk
John Rizk
JKJoseph Kaplinsky
Joseph Kaplinsky
RARasmus Agerholm
Rasmus Agerholm
DKDarshana Kadekar
Darshana Kadekar
FIFredrik Ivars
Fredrik Ivars
VBVasileios Bekiaris
Vasileios Bekiaris
By promoting noncanonical NF-κB signaling, SMAC mimetics can reprogram CD4 + T helper cell differentiation and curb autoimmunity.